A share price of Gilead Sciences, Inc [GILD] is currently trading at $125.67, up 0.38%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GILD shares have gain 3.55% over the last week, with a monthly amount glided 0.32%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Scotiabank started tracking the stock with Sector Outperform rating on November 13, 2025, and set its price target to $140. On August 19, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $128 on the stock. Truist upgraded its rating to a Buy but stick to its price target of $127 on August 08, 2025. Needham upgraded its rating to a Buy but $133 remained the price target by the analyst firm on July 25, 2025. In a note dated March 04, 2025, Oppenheimer reiterated an Outperform rating on this stock and boosted its target price from $115 to $132.
Gilead Sciences, Inc experienced fluctuations in its stock price throughout the past year between $88.57 and $128.70. Currently, Wall Street analysts expect the stock to reach $132.58 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $125.67 at the most recent close of the market. An investor can expect a potential return of 5.5% based on the average GILD price forecast.
Analyzing the GILD fundamentals
Trailing Twelve Months sales for Gilead Sciences, Inc [NASDAQ:GILD] were 29.05B which represents 3.36% growth. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.34%, and Net Profit Margin reading is 0.28%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 0.41 and Total Capital is 0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 125.11 points at the first support level, and at 124.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 126.24, and for the 2nd resistance point, it is at 126.81.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Gilead Sciences, Inc [NASDAQ:GILD] is 1.45. As well, the Quick Ratio is 1.31, while the Cash Ratio is 0.76. Considering the valuation of this stock, the price to sales ratio is 5.37, the price to book ratio is 7.25 and price to earnings (TTM) ratio is 19.47.
Transactions by insiders
Recent insider trading involved Dickinson Andrew D, Chief Financial Officer, that happened on Dec 15 ’25 when 3000.0 shares were sold. Chief Commercial Officer, Mercier Johanna completed a deal on Dec 15 ’25 to sell 3000.0 shares. Meanwhile, Officer JOHANNA MERCIER bought 3000.0 shares on Dec 15 ’25.
